× Silymarin and diabetic nephropathy

× Comment on: Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients

× Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients

× Serum uric acid and diabetic nephropathy

× Ginger and diabetic nephropathy

× Renoprotective effects of garlic

× On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view

× Combination of metformin with other antioxidants may increase its renoprotective efficacy

× Effect of Salvia officinalis on diabetic patients

× Complexity of diabetic nephropathy pathogenesis and design of investigations

× Metformin and renal injury protection

× AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients

× Diabetes and end-stage renal disease; a review article on new concepts

× IgA-dominant post-infectious glomerulonephritis; making another case in support of renal biopsy in type 2 diabetic nephropathy

× Tempol effects on diabetic nephropathy in male rats  

× Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

× Association between the methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms and the risk of diabetic nephropathy; a meta-analysis

× Association between serum insulin like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 levels and chronic kidney disease in diabetic patients

× Urinary neutrophil gelatinase-associated lipocalin in early detection of diabetic nephropathy; a pilot study

× The potential effects of dietary flavones on diabetic nephropathy; a review of mechanisms

× Effect of allopurinol on diabetic nephropathy; a double-blind clinical trial study

× Lack of association between diabetic nephropathy and human leukocyte antigen type 2 (HLA II-DQ1) in patients with type 2 diabetes mellitus in west of Iran

× Ameliorative impact of sodium–glucose cotransporter-2 inhibitors in diabetic kidney disease; a mini- review to current evidence

× Adipose derived mesenchymal stem cells and their role in management of kidney diseases